How do I read and understand my Stomach Cancer pathology report

Understanding Your Stomach Cancer Pathology Report

I'm glad you're taking an active role in understanding your [ID removed] A pathology report is one of the most important documents in your cancer care—it describes what the pathologist found when examining your tissue sample under the microscope. Let me walk you through what you'll typically see and what it means.

THE MAIN SECTIONS OF YOUR REPORT

1. SPECIMEN INFORMATION

This section describes what tissue was sent to the lab:

• Type of specimen: Biopsy (small tissue sample), endoscopic resection (tissue removed during an endoscopy), or surgical resection (tissue removed during surgery)
• Location in stomach: Cardia (top), fundus, body, antrum (bottom), or pylorus (outlet)
• Number of biopsies: According to NCCN Guidelines for Gastric Cancer, doctors typically take 6-8 biopsies to get adequate tissue for accurate diagnosis

What this means for you: The location matters because it affects staging and treatment planning. More biopsies generally give pathologists better information.

---

2. DIAGNOSIS/HISTOLOGIC TYPE

This tells you what kind of cancer cells were found:

Common types in stomach cancer:

• Adenocarcinoma (most common—about 90% of gastric cancers)
• Signet ring cell carcinoma (a subtype of adenocarcinoma with a specific appearance)
• Squamous cell carcinoma (less common)

What this means for you: The cell type helps determine treatment options. Your oncologist will use this information to recommend specific therapies.

---

3. GRADE (DIFFERENTIATION)

This describes how much the cancer cells look like normal stomach cells:

| Grade | What It Means | |-------|---------------| | Well-differentiated | Cancer cells look fairly normal; typically slower-growing | | Moderately differentiated | Cancer cells look somewhat abnormal | | Poorly differentiated | Cancer cells look very abnormal; typically more aggressive |

What this means for you: Grade helps predict how quickly the cancer might grow and spread. Poorly differentiated cancers often require more aggressive treatment.

---

4. DEPTH OF INVASION (T-STAGE)

This is critical—it describes how deep the cancer has invaded into the stomach wall:

The stomach wall has layers (from inside to outside):

• Mucosa (innermost lining)
• Submucosa (layer beneath the lining)
• Muscularis propria (muscle layer)
• Serosa (outer covering)

Depth categories:

• Tis (Carcinoma in situ): Cancer only in the innermost layer—earliest stage
• T1a: Invades mucosa only
• T1b: Invades submucosa
• T2: Invades muscularis propria (muscle layer)
• T3: Invades through the muscle into the tissue beyond
• T4a: Invades the serosa (outer lining)
• T4b: Invades into nearby organs (liver, pancreas, spleen)

What this means for you: Deeper invasion generally means more advanced disease and may affect whether surgery is recommended. According to NCCN Guidelines, endoscopic ultrasound (EUS) is recommended to accurately determine depth, especially for early-stage cancers.

---

5. LYMPH NODE STATUS (N-STAGE)

Lymph nodes are small immune system organs. Cancer cells often spread to nearby lymph nodes first:

• N0: No cancer in lymph nodes
• N1: Cancer in 1-2 nearby lymph nodes
• N2: Cancer in 3-6 nearby lymph nodes
• N3: Cancer in 7 or more nearby lymph nodes

Important detail: NCCN Guidelines recommend that at least 16 regional lymph nodes should be removed and examined during surgery for accurate staging.

What this means for you: More lymph nodes involved generally means higher stage disease. This significantly affects treatment recommendations.

---

6. LYMPHOVASCULAR INVASION (LVI)

This describes whether cancer cells were found inside blood vessels or lymphatic vessels:

• Present: Cancer cells have invaded blood/lymph vessels (more aggressive)
• Absent: No invasion into vessels (better prognostic sign)

What this means for you: If LVI is present, it suggests the cancer has a higher risk of spreading and typically leads to more intensive treatment recommendations.

---

7. MARGINS

This applies if you had surgical resection or endoscopic resection:

• R0 (negative margins): No cancer cells at the edges—the surgeon removed all visible cancer
• R1 (positive margins): Cancer cells found at the edge—some cancer may remain
• R2 (macroscopic residual disease): Visible cancer left behind

What this means for you: R0 is the goal. If margins are positive, additional treatment (chemotherapy, radiation, or re-surgery) may be recommended.

---

8. BIOMARKER TESTING ⭐ INCREASINGLY IMPORTANT

According to NCCN Guidelines, universal testing is now recommended for all newly diagnosed gastric cancer patients. These tests identify specific characteristics that guide treatment:

Key biomarkers to look for:

| Biomarker | What It Tests | Why It Matters | |-----------|---------------|----------------| | MSI (Microsatellite Instability) or MMR (Mismatch Repair) | Whether DNA repair mechanisms are working | MSI-high or dMMR tumors may respond to immunotherapy | | PD-L1 | A protein on cancer cells that helps them hide from immune system | Helps predict response to immunotherapy | | HER2 | Growth-promoting protein | HER2-positive cancers can be treated with targeted therapy (trastuzumab/Herceptin) | | CLDN18.2 | A protein on cell surface | CLDN18.2-positive cancers may respond to specific targeted therapies | | NGS (Next-Generation Sequencing) | Comprehensive genetic analysis | Identifies multiple mutations that might have targeted treatment options |

What this means for you: These tests are crucial for determining which treatments might work best for YOUR specific cancer. Ask your doctor which tests were done on your sample.

---

PUTTING IT TOGETHER: UNDERSTANDING YOUR STAGE

Your pathology report provides the T, N, and M components that determine your overall stage:

• T = Tumor depth (how deep it invades)
• N = Lymph nodes (how many involved)
• M = Metastasis (whether it spread to distant organs)

Example: A report might say "pT3, N2, M0" meaning:

• The cancer invaded through the muscle layer (T3)
• Cancer was found in 3-6 lymph nodes (N2)
• No distant metastases were found (M0)

This would typically be Stage IIIB gastric cancer.

---

QUESTIONS TO ASK YOUR DOCTOR ABOUT YOUR PATHOLOGY REPORT

1. "What is the exact stage of my cancer based on this pathology report?"

2. "Which biomarker tests were performed on my tumor, and what were the results?" (Make sure MSI/MMR, PD-L1, HER2, and CLDN18.2 were tested)

3. "What do the results of these biomarker tests mean for my treatment options?"

4. "Were the margins negative (R0)? If not, what does that mean for my treatment plan?"

5. "How many lymph nodes were examined, and how many contained cancer?"

6. "Based on the depth of invasion and other findings, am I a candidate for surgery, and if so, when?"

7. "What is the grade of my cancer, and what does that tell us about how it might behave?"

8. "Are there any other findings in this report I should understand?"

---

IMPORTANT CONTEXT: HOW DOCTORS USE THIS INFORMATION

According to NCCN Guidelines for Gastric Cancer, your pathology report guides critical decisions:

• For early-stage disease (T1): Endoscopic resection may be curative
• For locally advanced disease (T2-T4